findmyKOL
Clinical trialNCT01875874TerminatedPhase 2Interventional

Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)

SponsorVital Therapies, Inc.Enrollment8Acute Liver FailureFulminant Hepatic FailurePrimary Graft Non-FunctionSurgically-Induced Liver Failure
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Keck Hospital of Usc

    Los Angeles, California, United States

  • Georgetown University Hospital

    Washington D.C., District of Columbia, United States

  • University of Miami Hospital

    Miami, Florida, United States

  • Tampa General Hospital

    Tampa, Florida, United States

  • Cleveland Clinic Floriday

    Weston, Florida, United States

  • Emory University Hospital

    Atlanta, Georgia, United States

  • Piedmont Atlanta Hospital

    Atlanta, Georgia, United States

  • Rush University Medical Center

    Chicago, Illinois, United States

  • Massachusetts General Hospital

    Boston, Massachusetts, United States

  • University of Minnesota Medical Center - Twin Cities Campus

    Minneapolis, Minnesota, United States

  • Rutgers University Hospital

    Newark, New Jersey, United States

  • New York University Medical Center

    New York, New York, United States

  • Montefiore Medical Center

    The Bronx, New York, United States

  • Cleveland Clinic Foundation

    Cleveland, Ohio, United States

  • Drexel University College of Medicine

    Philadelphia, Pennsylvania, United States

  • Methodist Dallas Medical Center - the Liver Institute

    Dallas, Texas, United States

  • University of Utah

    Salt Lake City, Utah, United States

  • Swedish Medical Center

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Oct 2014
Primary completion
30 Sept 2015
Completion
30 Sept 2018
Last update posted
12 Feb 2019
Registered enrollment
8
Registry id
NCT01875874

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.